Coronavirus Vaccine Shows Promise For Older Adults In A Study
Moderna researchers published a safety study that said the vaccine provided older adults with levels of antibodies similar to younger people.
There's some good news about a coronavirus vaccine tested on older adults — a group more susceptible to severe complications from COVID-19.
Researchers at Moderna published results of a safety study Tuesday that said the vaccine provided older adults with levels of antibodies similar to younger people.
The researchers said side effects were mild and could be compared with a high-dose flu shot.
The vaccine is in Phase 3 trials — a necessary step before it can be considered for release.
Moderna defends vax price hike, despite billions in taxpayer funding
The company is planning to raise the price of its COVID-19 vaccine from about $26 per dose up to $130 per dose.
What living with long COVID is really like
Scripps News talked to a dozen people with long-term COVID symptoms about their current experience and their hope for the future.
New data links COVID-19 pandemic's origins to raccoon dogs
The discovery does not prove that raccoon dogs or any other animals infected with COVID triggered the pandemic.
Biden's Justice Dept. keeps hard line in death row cases
Death penalty opponents are frustrated Biden hasn't taken any steps to fulfill his campaign promise to end capital punishment at the federal level.
Jonathan Majors arrested on assault charge in New York
The star of recently-released "Creed III" and "Ant-Man and The Wasp: Quantumania," was involved in a domestic dispute involving a 30-year-old woman.
Daylight savings dispute leaves Lebanon with two time zones
Many Lebanese have found themselves in the position of juggling work and school schedules in different time zones.